Description: Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Home Page: adherathera.com
8000 Innovation Parkway
Baton Rouge,
LA
70820
United States
Phone:
919 518 3748
Officers
| Name | Title |
|---|---|
| Dr. Zahed Subhan B.S., BS, L.L.B., LLB (Law), M.B.A., M.S., MBA, MS | CEO, Chief Scientific Officer & Chairman |
| Mr. Andrew Albert Kucharchuk M.B.A. | COO, CFO, Corp. Devel. and Investor Relations & Vice Chairman |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 8.2348 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |